CYBERMED LIFE - ORGANIC  & NATURAL LIVING

HPV

  • Big Pharma suppresses the evidence on dangerous or useless drugs

    facebook Share on Facebook
    Big Pharma suppresses the evidence on dangerous or useless drugs image

    Pharmaceutical companies are deliberately misleading health agencies and governments by suppressing research that reveals a drug doesn't work or is dangerous. At least half of all medical trials are never published.

    In one example, governments were hoodwinked into stockpiling Tamiflu during the swine flu scare of 2009—but hadn't seen unpublished studies that found it wasn't effective. Around 80 per cent of the studies into the drug—that showed it didn't prevent complications after someone contracted flu—were either never published or hadn't been independently reviewed first.

  • CNS demyelination and quadrivalent HPV vaccination.

    facebook Share on Facebook
    Abstract Title:

    CNS demyelination and quadrivalent HPV vaccination.

    Abstract Source:

    Mult Scler. 2009 Jan;15(1):116-9. Epub 2008 Sep 19. PMID: 18805844

    Abstract Author(s):

    I Sutton, R Lahoria, Il Tan, P Clouston, Mh Barnett

    Abstract:

    Vaccination is generally considered safe in patients with multiple sclerosis (MS). We report five patients who presented with multifocal or atypical demyelinating syndromes within 21 days of immunization with the quadrivalent human papilloma virus (HPV) vaccine, Gardasil. Although the target population for vaccination, young females, has an inherently high risk for MS, the temporal association with demyelinating events in these cases may be explained by the potent immuno-stimulatory properties of HPV virus-like particles which comprise the vaccine. A prospective case-control study of patients with MS or clinically isolated demyelinating syndromes receiving the Gardasil vaccine may provide relevant safety data in this population.

  • Effective or ineffective: attribute framing and the human papillomavirus (HPV) vaccine. 📎

    facebook Share on Facebook
    Abstract Title:

    Effective or ineffective: attribute framing and the human papillomavirus (HPV) vaccine.

    Abstract Source:

    Patient Educ Couns. 2010 Sep 17. Epub 2010 Sep 17. PMID: 20851560

    Abstract Author(s):

    Cabral A Bigman, Joseph N Cappella, Robert C Hornik

    Article Affiliation:

    Center of Excellence in Cancer Communication Research, Annenberg School for Communication, University of Pennsylvania, Philadelphia, USA.

    Abstract:

    OBJECTIVE: To experimentally test whether presenting logically equivalent, but differently valenced effectiveness information (i.e. attribute framing) affects perceived effectiveness of the human papillomavirus (HPV) vaccine, vaccine-related intentions and policy opinions.

    METHODS: A survey-based experiment (N=334) was fielded in August and September 2007 as part of a larger ongoing web-enabled monthly survey, the Annenberg National Health Communication Survey. Participants were randomly assigned to read a short passage about the HPV vaccine that framed vaccine effectiveness information in one of five ways. Afterward, they rated the vaccine and related opinion questions. Main statistical methods included ANOVA and t-tests.

    RESULTS: On average, respondents exposed to positive framing (70% effective) rated the HPV vaccine as more effective and were more supportive of vaccine mandate policy than those exposed to the negative frame (30% ineffective) or the control frame. Mixed valence frames showed some evidence for order effects; phrasing that ended by emphasizing vaccine ineffectiveness showed similar vaccine ratings to the negative frame.

    CONCLUSION: The experiment finds that logically equivalent information about vaccine effectiveness not only influences perceived effectiveness, but can in some cases influence support for policies mandating vaccine use.

    PRACTICE IMPLICATIONS: These framing effects should be considered when designing messages.

  • HPV

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.